Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
HALO Coverage
Transcript
Halozyme Therapeutics, Inc (HALO) Q4 2025 Earnings Call Transcript
Mar 10, 2026
Event
Halozyme Therapeutics, Inc (HALO) U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
Mar 6, 2026
Event
Halozyme Therapeutics, Inc (HALO) Leerink Partners Global Healthcare Conference
Feb 25, 2026
Event
Halozyme Therapeutics, Inc (HALO) TD Cowen 46th Annual Healthcare Conference
Feb 25, 2026
News
Halozyme Q4 2025 Earnings Surge: Royalty Revenue Soars 52%
Feb 17, 2026
Transcript
Halozyme Therapeutics, Inc (HALO) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Halozyme Therapeutics, Inc (HALO) Q3 2025 Earnings Call Transcript
Jan 22, 2026